#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12126	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2124	567.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1694	1694	T	662	T	614	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12126	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2124	567.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1428	1428	C	746	C	699	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22418	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3398	656.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1591	1591	A	749	A	690	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22418	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3398	656.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2225	2225	C	755	C	700	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22418	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3398	656.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2299	2299	A	728	A,T	688,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22418	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3398	656.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2851	2851	C	667	C	630	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1752	folP	855	855	99.88	folP.l15.c17.ctg.1	1614	108.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1091	1093	AGC	188;190;191	A;G;C	175;177;178	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4496	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3416	131.3	0	.	p	.	0	D95A	NONSYN	283	285	GAC	647	649	GCC	145;143;141	G;C;C	131;130;130	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4496	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3416	131.3	1	SNP	p	S91F	1	.	.	271	273	TTC	635	637	TTC	148;147;147	T;T;C	136;136;134	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1344	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1252	106.8	0	.	p	.	0	A39T	NONSYN	115	117	GCC	407	409	ACC	149;148;147	A,G;C;C	137,1;137;137	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1344	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1252	106.8	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	605	607	CAC	166;167;166	C;A;C	153;151;153	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1344	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1252	106.8	0	.	p	.	0	A127fs	FSHIFT	379	379	G	671	671	G	167	GCCCC,GCCC	159,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1344	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1252	106.8	1	SNP	p	G45D	0	.	.	133	135	GGC	425	427	GGC	151;153;155	G;G;C	138;144;144	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	788	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	885	88.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4042	parC	2304	2304	99.87	parC.l15.c30.ctg.1	3117	129.3	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1516	1518	GTC	162;162;162	G;T;C	145;147;147	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4042	parC	2304	2304	99.87	parC.l15.c30.ctg.1	3117	129.3	1	SNP	p	D86N	0	.	.	256	258	GAC	622	624	GAC	156;158;159	G;A;C	151;149;152	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4042	parC	2304	2304	99.87	parC.l15.c30.ctg.1	3117	129.3	1	SNP	p	R87I	0	.	.	259	261	CGT	625	627	CGT	158;161;160	C,A;G;T	151,1;153;150	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4042	parC	2304	2304	99.87	parC.l15.c30.ctg.1	3117	129.3	1	SNP	p	S87R	1	.	.	259	261	CGT	625	627	CGT	158;161;160	C,A;G;T	151,1;153;150	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4042	parC	2304	2304	99.87	parC.l15.c30.ctg.1	3117	129.3	1	SNP	p	R87W	0	.	.	259	261	CGT	625	627	CGT	158;161;160	C,A;G;T	151,1;153;150	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4042	parC	2304	2304	99.87	parC.l15.c30.ctg.1	3117	129.3	1	SNP	p	S88P	0	.	.	262	264	TCC	628	630	TCC	161;160;161	T;C;C	153;151;154	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3712	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2593	142.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1492	1494	GGC	184;181;179	G;G;C	170;165;165	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1167	1169	GCA	194;196;196	G;C;A	176;176;178	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1170	1172	ATC	196;196;199	A;T;C	181;181;182	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1182	1184	GTG	193;193;194	G;T;G	177;173;176	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1182	1184	GTG	193;193;194	G;T;G	177;173;176	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1686	1688	ACC	184;182;182	A;C;C	167;165;168	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1740	1742	GCG	166;166;165	G;C;G	147;128;138	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1740	1742	GCG	166;166;165	G;C;G	147;128;138	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1863	1865	GGT	139;135;136	G;G;T	132;127;127	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1872	1874	GGC	125;127;126	G;G;C	114;112;111	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3402	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2411	140.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1890	1892	CCG	116;120;121	C,T,G;C;G	82,1,1;88;83	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4988	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3026	164.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1588	1590	CCG	181;179;180	C;C;G	161;167;162	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1902	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1704	110.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	502	502	C	121	C,T,G	106,1,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2550	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1565	161.9	0	.	p	.	0	R143G	NONSYN	427	429	AGA	716	718	GGA	200;200;201	G,A;G,A;A	190,1;189,1;187	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2550	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1565	161.9	0	.	p	.	0	.	INDELS	629	630	AA	919	921	TAG	204;201;200	T;A;G	196;193;192	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2550	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1565	161.9	0	.	p	.	0	.	MULTIPLE	631	633	TAC	923	926	CAAT	198;199;198;194	C;A;A;T	188;189;189;179	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2550	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1565	161.9	0	.	p	.	0	N212fs	FSHIFT	634	634	A	928	928	T	195	T	186	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2550	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1565	161.9	1	SNP	p	G120K	0	.	.	358	360	GGT	647	649	GGT	229;229;231	G;G,C;T,C	213;211,1;206,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2550	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1565	161.9	1	SNP	p	A121D	0	.	.	361	363	GCC	650	652	GCC	232;229;229	G,A;C,G;C	213,1;211,1;215	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2550	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1565	161.9	1	SNP	p	A121N	0	.	.	361	363	GCC	650	652	GCC	232;229;229	G,A;C,G;C	213,1;211,1;215	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9452	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4836	194.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1972	1974	AAT	196;194;194	A;A;T	182;179;180	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	968	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	857	111.0	1	SNP	p	V57M	1	.	.	169	171	ATG	448	450	ATG	202;202;203	A;T;G	187;186;187	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	M177T	NONSYN	529	531	ATG	977	979	ACG	460;452;451	A;C;G	439;436;436	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	998	1000	GAC	386;384;384	G;A;C	384;381;384	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1016	1018	ATG	376;377;377	A;T;G	376;374;374	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1028	1030	TCA	370;372;371	T;CA,C;A	367;369,1;371	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1073	1075	CAG	356;358;363	C;A;G	353;355;359	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1094	1096	CTT	350;350;349	C;T;T	349;347;346	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1115	1117	AGT	353;363;363	A;G;T,A	349;353;351,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1184	1186	CCG	511;514;516	C;C;G	482;485;488	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1286	1288	TCG	573;571;572	T;C;G	535;532;540	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1457	1459	AAA	296;291;285	A;A;A	287;283;279	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1460	1462	AAG	275;273;270	A;A;G	270;268;262	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1475	1477	CAC	235;235;236	C;A;C	233;225;235	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1514	1516	GAA	233;229;230	G;A;A	232;229;230	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1592	1594	ACG	193;192;188	A;C;G	191;190;185	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1643	1645	ATT	257;255;257	A;T;T	241;243;244	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1646	1648	AGT	259;258;256	A;G,T;T	244;243,1;238	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1685	1687	CTA	287;285;293	C;T;A	273;274;281	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1727	1729	AAT	210;211;212	A;A;T,A	202;203;202,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1796	1798	TCA	271;276;277	T;C,A;A	259;267,1;265	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1820	1822	ATG	286;286;287	A;T;G	277;278;276	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2114	2116	ACC	575;574;575	A;C;C	542;542;541	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10918	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2702	402.9	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2210	2212	GAA	590;590;594	G;A;A	548;548;553	.	Tetracycline resistance
